Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

1800-272-662
Shopping Cart 0
countryflagAU
Login

Home CompaniesPrestige Brand Holdings Inc

Prestige Brand Holdings Inc

Healthcare Drug Manufacturers - Specialty & Generic
PortfolioPortfolio WatchlistWatchlist
Company price
44.17 USD -0.80 ( 1.78%)
Last update at 2026-11-11T21:00:00Z
VOLUME
386229
Market Cap
2211.44M
P/E
13.08

Momentum Score

…

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. It operates in two segments, North American OTC Healthcare and International OTC Healthcare. The company offers analgesic powders under the BC and Goody's brand; various diaper rash treatments and skin protectants for babies under the Boudreaux's Butt Paste brand name; sprays and lozenges to relieve sore throats and mouth pain under the Chloraseptic brand; eye care products that provide relief from redness and itchiness under the Clear Eyes brand name; at-home removal of common and plantar warts under the Compound W brand; and ear wax removal products under the Debrox brand name. It also provides dental guards, floss picks, interdental brushes, dental repair and kits, and tongue cleaners under the DenTek brand; motion sickness relief products under the Dramamine brand; enemas and other laxative products under the Fleet brand name; stomach upset remedies under the Gaviscon brand; cough drops under the Luden's brand; products for yeast infections in women under the Monistat brand name; lice and parasite treatments under the Nix name; feminine care products, including washes, cloths, and sprays under the Summer's Eve brand; products for dry eyes under the TheraTears brand; nasal saline sprays and washes under the Fess brand name; and oral rehydration products under the Hydralyte brand. It sells its products to mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
43.69
Low
44.78
High
52 Week Price Range
42.62
Low
71.07
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
44.97
Dividend Yield
-
Revenue TTM
1104.88M
Revenue Per Share
23.04
Gross Profit TTM
605.18M
Debt / Equity
0.55
ROE
9.12%
Net Debt
981.56M
ROCE
8.75%
Diluted EPS TTM
3.57

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2026-03-31 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Type yearly yearly yearly yearly yearly
Date 2026-03-31 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Income before tax 257.50M 284.19M 276.02M -93.92M 262.46M
Net income 190.30M 214.60M 209.34M -82.31M 205.38M
Selling general administrative 116.45M 108.21M 106.15M 107.35M 108.52M
Selling and marketing expenses 148.78M 155.72M 153.31M 145.06M 157.34M
Gross profit 574.64M 634.46M 624.45M 625.29M 620.65M
Reconciled depreciation 31.27M 30.17M 30.68M 32.62M 32.09M
Ebit 299.83M 331.82M 343.19M 345.47M 329.92M
Ebitda 331.11M 361.99M 373.86M 378.09M 360.96M
Depreciation and amortization 31.27M 30.17M 30.68M 32.62M 31.04M
Non operating income net other - - - -2.34M -3.17M
Operating income 309.41M 336.77M 342.43M 345.47M 329.92M
Other operating expenses 779.30M 800.99M 782.93M 779.92M 756.89M
Interest expense 42.34M 47.63M 67.16M 69.16M 64.29M
Tax provision 67.19M 69.58M 66.69M -11.61M 57.08M
Interest income - 47.63M 67.16M 69.16M 64.29M
Net interest income -42.34M -47.63M -67.16M -69.16M -64.29M
Non recurring - - - 370.22M -
Income tax expense 67.19M 69.58M 66.69M -11.61M 57.08M
Total revenue 1088.70M 1137.76M 1125.36M 1127.72M 1086.81M
Total operating expenses 265.23M 297.69M 282.02M 277.49M 290.73M
Cost of revenue 514.07M 503.30M 500.91M 502.43M 466.17M
Total other income expense net -51.91M -52.59M -66.40M -439.38M -67.46M
Net income from continuing ops 190.30M 214.60M 209.34M -82.31M 205.38M
Net income applicable to common shares - 214.60M 209.34M -82.31M 205.38M
Breakdown 2026-03-31 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Type yearly yearly yearly yearly yearly
Date 2026-03-31 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Total assets 3547.57M 3402.22M 3318.42M 3353.73M 3670.68M
Intangible assets 2299.61M 2295.35M 2320.58M 2341.89M 2696.64M
Other current assets 16.56M 8.44M 13.08M 4.12M 6.41M
Total liab 1660.05M 1567.32M 1663.33M 1906.64M 2093.07M
Total stockholder equity 1887.52M 1834.90M 1655.08M 1447.08M 1577.61M
Other current liab 85.58M 78.33M 69.35M 88.21M 78.55M
Common stock 0.56M 0.56M 0.56M 0.55M 0.54M
Capital stock 0.56M 0.56M 0.56M 0.55M 0.54M
Retained earnings 1746.10M 1555.80M 1341.20M 1131.86M 1214.16M
Other liab - - - - 452.40M
Good will 581.11M 527.42M 527.73M 527.55M 578.98M
Other assets - 3.27M 0.00M 3.00M 3.27M
Cash 63.87M 97.88M 46.47M 58.49M 27.18M
Cash and equivalents - 97.88M 46.47M 58.49M 27.18M
Total current liabilities 120.92M 106.62M 117.05M 160.72M 143.42M
Current deferred revenue - - 2.57M - -
Net debt 981.56M 946.37M 1093.19M 1308.60M 1479.17M
Short term debt 12.55M 8.54M 6.15M 9.76M 9.11M
Short long term debt 2.99M - - - -
Short long term debt total 1045.43M 1044.25M 1139.66M 1367.09M 1506.36M
Other stockholder equity 169.22M 316.19M 347.83M 346.24M 381.94M
Property plant equipment - 127.84M 89.33M 70.41M 71.30M
Total current assets 431.48M 448.33M 375.04M 391.74M 293.27M
Net tangible assets - - - 1447.08M 1577.61M
Net receivables 191.92M 194.29M 176.78M 167.02M 139.33M
Long term debt 993.95M 992.36M 1125.80M 1345.79M 1476.66M
Inventory 159.13M 147.71M 138.72M 162.12M 120.34M
Accounts payable 22.79M 18.93M 38.98M 62.74M 55.76M
Accumulated other comprehensive income -28.37M -37.66M -34.49M -31.56M -19.03M
Common stock total equity - - - 0.55M 0.54M
Retained earnings total equity - - - 1131.86M 1214.16M
Treasury stock - - - - -133.65M
Non currrent assets other 2.17M 3.27M 5.72M -377.43M 3.27M
Non current assets total 3116.09M 2953.89M 2943.37M 2961.99M 3377.41M
Capital lease obligations 48.49M 51.89M 13.85M 21.30M 29.70M
Long term debt total - 1012.98M 1125.98M 1347.45M 1481.16M
Breakdown 2026-03-31 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Type yearly yearly yearly yearly yearly
Date 2026-03-31 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Investments - -17.45M -20.11M -11.58M -256.51M
Change to liabilities - - - 18.00M 18.77M
Total cashflows from investing activities -136.84M -17.45M -20.11M -11.58M -256.51M
Net borrowings 0.50M -139.54M -227.83M -135.00M -9.11M
Total cash from financing activities -156.06M -182.07M -241.01M -185.85M -7.57M
Change to operating activities - - - - 3.89M
Net income 190.30M 214.60M 209.34M -82.31M 205.38M
Change in cash -34.02M 51.41M -12.02M 31.30M -5.12M
Begin period cash flow 97.88M 46.47M 58.49M 27.18M 32.30M
End period cash flow 63.87M 97.88M 46.47M 58.49M 27.18M
Total cash from operating activities 257.63M 251.51M 248.93M 229.72M 259.92M
Depreciation 31.27M 30.17M 30.68M 32.62M 32.09M
Other cashflows from investing activities -1.93M -9.23M -10.56M -3.80M -246.87M
Change to inventory -1.60M -9.31M 24.44M -42.23M 0.66M
Change to account receivables -3.69M -16.33M -6.32M -24.93M -24.65M
Sale purchase of stock -156.28M -51.51M -25.00M -50.00M 7.04M
Other cashflows from financing activities -4.57M -5.83M 11.81M 14.53M 680.01M
Change to netincome - - - 322.58M 22.46M
Capital expenditures 11.18M 8.22M 9.55M 7.78M 9.64M
Change receivables - - - -24.93M -24.65M
Cash flows other operating - - - 1.61M 0.98M
Cash and cash equivalents changes - - - 32.29M -4.16M
Change in working capital -17.62M -41.94M -39.83M -53.85M -10.95M
Stock based compensation 10.84M 11.16M 14.01M 12.40M 9.04M
Other non cash items 20.14M 23.11M 11.66M 381.61M 14.38M
Free cash flow 246.45M 243.29M 239.38M 221.93M 250.28M

Peer Comparison*

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
PBH
Prestige Brand Holdings Inc		 -0.80
1.78%		 44.17 13.08 10.71 2.00 1.18 3.83 13.54
MKKGY
Merck KGaA ADR		 0.13
0.39%		 33.80 21.25 14.93 3.10 2.14 3.60 12.98
MKGAF
MERCK Kommanditgesellschaft auf Aktien		 -
-%		 169.12 24.86 15.11 3.13 1.98 3.08 18.89
TAK
Takeda Pharmaceutical Co Ltd ADR		 -
-%		 20.84 - 10.96 0.01 1.20 2.94 23.11
TKPHF
Takeda Pharmaceutical Co. Ltd.		 -
-%		 41.72 - 10.66 0.01 1.16 2.94 23.11

Profile*

Prestige Brand Holdings Inc

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. It operates in two segments, North American OTC Healthcare and International OTC Healthcare. The company offers analgesic powders under the BC and Goody's brand; various diaper rash treatments and skin protectants for babies under the Boudreaux's Butt Paste brand name; sprays and lozenges to relieve sore throats and mouth pain under the Chloraseptic brand; eye care products that provide relief from redness and itchiness under the Clear Eyes brand name; at-home removal of common and plantar warts under the Compound W brand; and ear wax removal products under the Debrox brand name. It also provides dental guards, floss picks, interdental brushes, dental repair and kits, and tongue cleaners under the DenTek brand; motion sickness relief products under the Dramamine brand; enemas and other laxative products under the Fleet brand name; stomach upset remedies under the Gaviscon brand; cough drops under the Luden's brand; products for yeast infections in women under the Monistat brand name; lice and parasite treatments under the Nix name; feminine care products, including washes, cloths, and sprays under the Summer's Eve brand; products for dry eyes under the TheraTears brand; nasal saline sprays and washes under the Fess brand name; and oral rehydration products under the Hydralyte brand. It sells its products to mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.

660 White Plains Road, Tarrytown, NY, United States, 10591

914 524 6800

https://www.prestigebrands.com

890

Name Title Year Born
Mr. Ronald M. Lombardi Chairman, Pres & CEO 1964
Ms. Christine Sacco Chief Financial Officer 1976
Mr. Jeffrey Zerillo Sr. VP of Operations 1961
Mr. William C. P'Pool Sr. VP, Gen. Counsel & Corp. Sec. 1965
Mr. Adel Mekhail Exec. VP of Marketing & Sales 1961
Mr. Philip David Terpolilli Director of Investor Relations NA
Dean Siegal Director of Communications NA
Ms. Mary Beth Fritz Sr. VP of Quality & Regulatory Affairs NA
Mr. Ronald M. Lombardi CPA Chairman, President & CEO 1964
Ms. Christine Sacco CPA CFO & COO 1976

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

CU6
AUD 2.05
+23.49%
DMP
AUD 25.06
+12.93%
G6M
AUD 2.74
+10.93%
XRO
AUD 75.17
+6.08%
SGR
AUD 0.17
+6.06%
AXQ
AUD 3.07
-18.35%
BOE
AUD 1.50
-9.39%
GQG
AUD 0.71
-8.97%
MI6
AUD 0.81
-8.52%
ELV
AUD 3.73
-8.35%

Equity Sectors*

  • Basic Materials

    -3.09%

  • Communication Services

    +0.75%

  • Consumer Cyclical

    +0.43%

  • Consumer Defensive

    +0.12%

  • Energy

    -1.07%

  • Financial Services

    -0.02%

  • Healthcare

    +1.08%

  • Industrials

    -0.22%

  • Real Estate

    +0.61%

  • Technology

    -1.69%

  • Utilities

    -0.18%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…